Over the years, startup investors have poured billions of dollars into DNA testing companies. To date, the results have delivered both huge successes and flops. We take a look at both.
After raising $300 million in April, data security startup Cyera closed another $300 million windfall at more than twice its previous valuation.
Today, the focus for most SaaS companies is on profitable revenue rather than growth, writes Bryan House, president at Elastic Path. In Part 2 of his Post-ZIRP survival series, House provides some...
Stay up to date with recent funding rounds, acquisitions, and more with the Crunchbase Daily.
67.1K Followers